Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoprofen transdermal patch versus ibuprofen tablet for post-endodontic pain
IRCT20190716044230N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ketoprofen and ibuprofen in irreversible pulpitis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Post-operative pain control at 48 hours. Started Sep 2020; status: completed.
02
Drugs
ketoprofenibuprofen
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20190716044230N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190716044230N1.